Loading clinical trials...

Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening | Clinical Trials | Clareo Health

RECRUITINGNA

Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening

NCT06821009•Digital Health Navigation Solutions, Inc

View on ClinicalTrials.gov

Summary

mPATH-CRC (mobile Patient Technology for Health) is an automated direct-to-patient digital health program about colorectal cancer screening. The goal of this project is to test a cloud-based version of mPATH that patients can use at home independent of a scheduled medical visit. Patients will access mPATH on their own devices using a hyperlink sent via text message. The cloud version of mPATH will have the proven effective content of the tablet version, including the ability to request a screening test directly via the program. mPATH will then share this information with the patient's healthcare organization so screening can be arranged. This cloud-based version will be highly scalable, have broad reach, and be easy to support, making it a commercially viable product. This project will (1) test the reach and effectiveness of the mPATH web app in two different healthcare settings: a Fee-for-Service setting, and a value-based care setting; and (2) determine the value generated by mPATH in each healthcare setting.

Eligibility

Age

45 - 74 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Age 45-74 years
•2. Be identified in the electronic health record as due for routine CRC screening, defined as
•1. No colonoscopy in prior 10 years
•2. No flexible sigmoidoscopy in prior 5 years
•3. No CT colography in prior 5 years
•4. No FIT-DNA test (Cologuard) within prior 3 years
•5. No Fecal Occult Blood Test within prior 1 year
•3. Have a cell phone number listed in the EHR
•4. Have a preferred language of English or Spanish in the EHR
•5. Upcoming appointment within 9 to 16 days
+1 more criteria

Exclusion Criteria

•1. Prior diagnosis of colorectal cancer
•2. Prior history of total colectomy
•3. Currently enrolled in palliative care or Hospice
•4. Age over 65 AND currently enrolled in an Institutional SNP (I-SNP) or living in Long Term Care
•5. Age over 65 with frailty and advanced illness (as defined by the health system's My Panel metric which mirrors the HEDIS COL-E quality metric for CRC screening)

Locations (2)

Atrium Health Floyd

Rome, Georgia, United States

Atrium Health Wake Forest Baptist

Winston-Salem, North Carolina, United States

Key Dates

Start Date

June 9, 2025

Primary Completion Date

June 30, 2026

Completion Date

June 30, 2026

Last Updated

June 24, 2025

Enrollment

6,500

ESTIMATED participants

Conditions

Colorectal Cancer Screening

Interventions

mPATH-CRC

OTHER

Usual Care (Control)

OTHER

Contacts

Aliza Randazzo

CONTACT

1-336-716-0844 arandazz@wakehealth.edu

David Miller, MD, MS

CONTACT

1-336-713-5218 dmiller@wakehealth.edu

Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection

NCT06620627

Colorectal Cancer Screening

View study

RECRUITINGPHASE4

Bowel Preparation in Colonoscopy: Lactulose Vs Polyethyleneglycol, Randomized Double-blind Comparative Clinical Trial, Multicenter Study.

NCT06666556

Colorectal Cancer Screening

View study

ENROLLING_BY_INVITATIONNA

Patient Navigation for Colorectal Cancer Screening

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 24, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening

Inclusion Criteria

Exclusion Criteria

Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection

Bowel Preparation in Colonoscopy: Lactulose Vs Polyethyleneglycol, Randomized Double-blind Comparative Clinical Trial, Multicenter Study.

Patient Navigation for Colorectal Cancer Screening

Pilot Testing of a Colorectal Cancer Education Program

Effect of Patient Navigation on Colonoscopy Completion Screening Rate for Colorectal Cancer.

Test Up Now Education Program